Clinicopathological significance of concurrent ErbB receptor expression in human meningioma

Keyphrases

• Receptor Expression 100%
• ErbB Receptors 100%
• Brain Meningioma 100%
• Clinicopathological Significance 100%
• Receptor-interacting Protein Kinase 1 (RIPK1) 50%
• Human Epidermal Growth Factor Receptor 2 (HER2) 50%
• Meningioma 50%
• ErbB2 50%
• ErbB1 50%
• Clinical Data 25%
• Tumor 25%
• Meninges 25%
• Effective Treatment 25%
• Treatment Options 25%
• Clinical Intervention 25%
• Favorable Prognosis 25%
• Tumor Biology 25%
• Epidermal Growth Factor Receptor 25%
• Immunohistochemical Analysis 25%
• Malignancy Grade 25%
• Clinical Prognosis 25%
• Tumourigenesis 25%
• Recurring 25%
• HER4 25%
• ErbB4 25%
• Benign Histology 25%
• HER3 25%
• ErbB3 25%
• Objective Biomarker 25%
• Epidermal Growth Factor Receptor Family 25%
• EGFR1 25%

Medicine and Dentistry

• Receptor Expression 100%
• Epidermal Growth Factor Receptor 100%
• Meningioma 100%
• Upregulation 33%
• Receptor Protein 33%
• Diagnosis 16%
• Neoplasm 16%
• Biological Marker 16%
• Cancer 16%
• Meninx 16%
• Recurrent Disease 16%
• Clinical Intervention 16%
• Carcinogenesis 16%
• Tumor Biology 16%
• Receptor Family 16%

Biochemistry, Genetics and Molecular Biology

• Epidermal Growth Factor Receptor 100%
• Eicosanoid Receptor 33%
• Upregulation 33%
• Monospecific Antibody 16%
• Carcinogenesis 16%